Daewoong Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewoong Company Limited with three other
companies in this sector in South Korea:
Kwang Dong Pharmaceutical Company Limited
sales of 1.14 trillion Korean Won [US$1.01 billion]
of which 40%
Hanmi Pharmaceutical., Company Limited
(916.59 billion Korean Won [US$814.85 million]
of which 76%
was Medicine), and
Daewoong Pharmaceutical Company Limited
(960.31 billion Korean Won [US$853.71 million]
of which 101%
was Medicine Manufacture&Sale).
During the year ended December of 2017, sales at
Daewoong Company Limited were 1.12 trillion Korean Won (US$999.30 million).
increase of 10.7%
versus 2016, when the company's sales were 1.02 trillion Korean Won.
This was the fifth consecutive year of sales increases at Daewoong Company Limited
(and since 2012, sales have increased a total of 282%).
Sales of Medicinal Manufacturing and Selling saw an increase
9.6% in 2017, from
1.15 trillion Korean Won to 1.27 trillion Korean Won.
Not all segments of Daewoong Company Limited experienced an increase in sales in 2017:
sales of Real Estate Leasing fell 10.0% to 8.91 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).